A*STAR Spin-off NalaGenetics Launches Comprehensive Drug Reaction Screening for Leprosy Patients Across Indonesia
NalaGenetics, a pioneering spin-off from the Agency for Science, Technology and Research's (A*STAR) Genome Institute of Singapore, is poised to ...
